Cargando…
Making Statistical Sense of the Molnupiravir MOVe-OUT Clinical Trial
Oral therapies for the early treatment of COVID-19 may prevent disease progression and health system overcrowding. A new oral therapeutic named molnupiravir has been promoted as providing an approximately 50% reduction in death or the need for hospitalization. The clinical trial evaluating this drug...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Tropical Medicine and Hygiene
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128711/ https://www.ncbi.nlm.nih.gov/pubmed/35276667 http://dx.doi.org/10.4269/ajtmh.21-1339 |